Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 1 open-market purchase and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Lipocine Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 483.9K | 473.9K | −10.0K (−2.1%) |
| Value | $1.35M | $2.46M | +$1.12M (+83.1%) |
New holders (2)
Institutions that held Lipocine Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 431 | $2.24K | 0.00% |
| Old Point Trust & Financial Services N A | 59 | $307 | 0.00% |
Sold out (3)
Institutions that held Lipocine Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Wealth Effects LLC | 14,639 | $40.8K |
| FMR LLC | 90 | $248 |
| Bank of America Corp | 6 | $16 |